Vertical and horizontal geographic atrophy - A concept to overcome the current structure-function paradox.
作者信息
Siedlecki Jakob, Priglinger Siegfried
机构信息
Department of Ophthalmology, LMU University Hospital, LMU Munich, Munich, Germany.
出版信息
Eye (Lond). 2024 Oct;38(14):2665-2667. doi: 10.1038/s41433-024-03174-2. Epub 2024 Jun 21.
Abstract
摘要
相似文献
1
Vertical and horizontal geographic atrophy - A concept to overcome the current structure-function paradox.垂直与水平地理性萎缩——克服当前结构-功能悖论的一个概念。
Eye (Lond). 2024 Oct;38(14):2665-2667. doi: 10.1038/s41433-024-03174-2. Epub 2024 Jun 21.
2
Determinants of Four-Year Visual Acuity Loss in Geographic Atrophy: An Analysis of Age-Related Eye Disease Study and Age-Related Eye Disease Study 2.地图样萎缩四年视力丧失的决定因素：年龄相关性眼病研究及年龄相关性眼病研究2分析
Ophthalmology. 2025 Jul;132(7):785-798. doi: 10.1016/j.ophtha.2025.01.028. Epub 2025 Feb 5.
3
Structure-Function Relationships in Geographic Atrophy Based on Mesopic Microperimetry, Fundus Autofluorescence, and Optical Coherence Tomography.基于中视微视野计、眼底自发荧光和光学相干断层扫描的地图样萎缩中的结构-功能关系
Transl Vis Sci Technol. 2025 Feb 3;14(2):7. doi: 10.1167/tvst.14.2.7.
4
Age-related macular degeneration: natural history revisited in geographic atrophy.年龄相关性黄斑变性：地图样萎缩的自然病程再探讨。
Eye (Lond). 2025 Feb;39(2):217-227. doi: 10.1038/s41433-024-03443-0. Epub 2024 Oct 29.
5
Visual Acuity and Quality of Life Outcomes With Pegcetacoplan Treatment: A Post Hoc Analysis From the OAKS and DERBY Trials.培塞妥单抗治疗的视力和生活质量结果：来自OAKS和DERBY试验的事后分析
Am J Ophthalmol. 2025 Sep;277:471-481. doi: 10.1016/j.ajo.2025.05.023. Epub 2025 May 29.
6
Geographic atrophy: Understanding the relationship between structure and function.地图样萎缩：理解结构与功能之间的关系。
Asia Pac J Ophthalmol (Phila). 2025 May-Jun;14(3):100207. doi: 10.1016/j.apjo.2025.100207. Epub 2025 May 19.
7
Evaluating the Progression of Retinal Sensitivity Loss in Geographic Atrophy Using Machine-Learning-Based Structure-Function Correlation (OMEGA 2).使用基于机器学习的结构-功能相关性评估地图状萎缩中视网膜敏感度丧失的进展（OMEGA 2）。
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):34. doi: 10.1167/iovs.66.11.34.
8
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE.培西加单抗治疗年龄相关性黄斑变性地图状萎缩36个月：来自OAKS、DERBY和GALE的数据。
Am J Ophthalmol. 2025 Apr 23;276:350-364. doi: 10.1016/j.ajo.2025.04.016.
9
Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration.抗高温需求蛋白A1（HtrA1）Fab片段药物Galegenimab（FHTR2163）治疗年龄相关性黄斑变性继发地图样萎缩的2期研究
Am J Ophthalmol. 2025 Jul;275:14-26. doi: 10.1016/j.ajo.2025.03.021. Epub 2025 Mar 13.
10
The Use of Microperimetry to Detect Functional Progression in Non-Neovascular Age-Related Macular Degeneration: A Systematic Review.使用微视野检查法检测非新生血管性年龄相关性黄斑变性的功能进展：一项系统评价
Asia Pac J Ophthalmol (Phila). 2017 Jan-Feb;6(1):70-79. doi: 10.22608/APO.201643.
本文引用的文献
1
Macular Sensitivity Endpoints in Geographic Atrophy: Exploratory Analysis of Chroma and Spectri Clinical Trials.地图样萎缩中的黄斑敏感性终点：色度和光谱临床试验的探索性分析。
Ophthalmol Sci. 2023 Jun 12;4(1):100351. doi: 10.1016/j.xops.2023.100351. eCollection 2024 Jan-Feb.
2
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.培格司他单抗治疗与年龄相关的黄斑变性（OAKS 和 DERBY）相关的地图状萎缩：两项多中心、随机、双盲、假对照、3 期临床试验。
Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9.
3
The Issue of End Point Discordance in Dry Age-Related Macular Degeneration: How Might Clinical Trials Demonstrate a Functional Benefit?干性年龄相关性黄斑变性中的终点不一致问题：临床试验如何证明功能获益？
Ophthalmology. 2023 Sep;130(9):890-892. doi: 10.1016/j.ophtha.2023.05.020. Epub 2023 Jun 6.
4
Two potentially distinct pathways to geographic atrophy in age-related macular degeneration characterized by quantitative fundus autofluorescence.两种定量眼底自发荧光特征的年龄相关性黄斑变性中地理萎缩的潜在不同途径。
Eye (Lond). 2023 Aug;37(11):2281-2288. doi: 10.1038/s41433-022-02332-8. Epub 2023 Jan 9.
5
The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence-Based OCT Analysis.基于人工智能的 OCT 分析观察到培格司他单抗治疗对地理萎缩中感光细胞维持的影响。
Ophthalmol Retina. 2022 Nov;6(11):1009-1018. doi: 10.1016/j.oret.2022.05.030. Epub 2022 Jun 3.
6
SUBRETINAL DRUSENOID DEPOSITS AND SOFT DRUSEN: Are They Markers for Distinct Retinal Diseases?视网膜下硬性脂滴沉积和软性脂滴：它们是不同视网膜疾病的标志物吗？
Retina. 2022 Jul 1;42(7):1311-1318. doi: 10.1097/IAE.0000000000003460.
7
Inferred retinal sensitivity in recessive Stargardt disease using machine learning.使用机器学习推断隐性斯塔加特病的视网膜敏感性。
Sci Rep. 2021 Jan 14;11(1):1466. doi: 10.1038/s41598-020-80766-4.
8
Validation of an Automated Quantification of Relative Ellipsoid Zone Reflectivity on Spectral Domain-Optical Coherence Tomography Images.光谱域光学相干断层扫描图像上相对椭球区反射率自动定量的验证
Transl Vis Sci Technol. 2020 Oct 14;9(11):17. doi: 10.1167/tvst.9.11.17. eCollection 2020 Oct.
9
Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.由地理萎缩导致的视觉功能下降：Chroma 和 Spectri 第三阶段试验的结果。
Ophthalmol Retina. 2020 Jul;4(7):673-688. doi: 10.1016/j.oret.2020.01.019. Epub 2020 Jan 31.
10
Light Sensitivity Within Areas of Geographic Atrophy Secondary to Age-Related Macular Degeneration.与年龄相关性黄斑变性相关的地图状萎缩区域的光敏感性。
Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3992-4001. doi: 10.1167/iovs.19-27178.
Zotero 插件